Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |